Official Journal of Research Center for Gastroenterology and Liver Diseases

e-ISSN 1735-3408

p-ISSN 1735-143X

Citation data

CrossRef

Works that cite this article, indexed by Crossref.

21 resultsUpdated August 23, 2026

← Back to article

Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma

World Journal of Gastroenterology 22(37) (2016)

Stijn Van Hees; Peter Michielsen; Thomas Vanwolleghem

The role of PIVKA-II in hepatocellular carcinoma surveillance in an Asian population

Annals of the Academy of Medicine, Singapore 52(2) (2023)

Wai-Yoong Ng; Daniel Yan-Zheng Lim; Si-Yu Tan; Jason Pik-Eu Chang; Thinesh Lee Krishnamoorthy; Chee-Hooi Lim; Damien Meng-Yew Tan; Victoria Sze-Min Ekstrom; George Boon-Bee Goh; Mark Chang-Chuen Cheah; Rajneesh Kumar; Chin-Pin Yeo; Chee-Kiat Tan

A Novel LC‐MS/MS Assay for Quantification of Des‐carboxy Prothrombin and Characterization of Warfarin‐Induced Changes

Clinical and Translational Science 13(4) (2020)

Abdul Basit; Bhagwat Prasad; Joanne K. Estergreen; Daniel E. Sabath; Nathan Alade; David L. Veenstra; Allan E. Rettie; Kenneth E. Thummel

Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis

Scandinavian Journal of Gastroenterology 53(6) (2018)

Gian Paolo Caviglia; Davide Giuseppe Ribaldone; Maria Lorena Abate; Alessia Ciancio; Rinaldo Pellicano; Antonina Smedile; Giorgio Maria Saracco

Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis

Hepatobiliary & Pancreatic Diseases International 17(6) (2018)

Hao Xing; Yi-Jie Zheng; Jun Han; Han Zhang; Zhen-Li Li; Wan-Yee Lau; Feng Shen; Tian Yang

A novel model based on interleukin 6 and insulin-like growth factor II for detection of hepatocellular carcinoma associated with hepatitis C virus

Journal of Genetic Engineering and Biotechnology 19(1) (2021)

Mohamed M. Omran; Sara Mosaad; Tarek M. Emran; Fathy M. Eltaweel; Khaled Farid

New Thresholds for AFP and Des-γ-Carboxy Prothrombin in Chronic Liver Disease Depending on the Use of Nucleoside Analogs and an Integrated Nomogram

International Journal of General Medicine Volume 14 (2021)

Ting Sun; Ruicen Li; Yiwen Qiu; Shu Shen; Wentao Wang

Combining serologic biomarkers with the PAGE B score improves risk stratification for hepatocellular carcinoma development among chronic hepatitis B patients

Scientific Reports 15(1) (2025)

Michael Stec; Mark Anderson; Mary A. Rodgers; Tiffany Fortney; Danny Ka-Ho Wong; Lung-Yi Mak; Man-Fung Yuen; Gavin A. Cloherty

Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients

Scientific Reports 6(1) (2016)

Rentao Yu; Xiaomei Xiang; Zhaoxia Tan; Yi Zhou; Haoliang Wang; Guohong Deng

Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study

Oncotarget 8(52) (2017)

Huaping Chen; Siyuan Chen; Shan Li; Zhijian Chen; Xuan Zhu; Meiyu Dai; Lingxi Kong; Xiaodan Lv; Zhili Huang; Xue Qin

Evaluation of the diagnostic accuracy of des-gamma-carboxy prothrombin and alpha-fetoprotein alone or in combination for hepatocellular carcinoma: A systematic review and meta-analysis

Surgical Oncology 34 (2020)

Jia Fan; Yu Chen; Dan Zhang; Juan Yao; Zijun Zhao; Yao Jiang; Yiqin Li; Yongcan Guo

Diagnostic value of TAP, PIVKA-II, and AFP in hepatocellular carcinoma and their prognostic value for patients treated with transarterial chemoembolization

Laboratory Medicine 56(3) (2025)

Delu Gan; Yali Wang; Xin Yang; Juan Huang; Lijun Zhang; Bianqin Guo; Pu Li; Dan Gou

Levels of PIVKA-II and alpha-fetoprotein in unresectable hepatocellular carcinoma compared to healthy controls and predictive values of both markers with radiological responses after loco-regional interventions

PeerJ 11 (2023)

Norhanan Hamzah; Nur Karyatee Kassim; Julia Omar; Mohd Shafie Abdullah; Yeong Yeh Lee

Optimizing care of HBV infection and HBV-related HCC

Clinical Liver Disease 23(1) (2024)

Shi Yan Lee; Benjamin Kai Yi Nah; Jazleen Leo; Jia Hong Koh; Daniel Q. Huang

PIVKA-II combined with alpha-fetoprotein for the diagnostic value of hepatic tumors in children: a multicenter, prospective observational study

Hepatology International 18(4) (2024)

Hongxiang Gao; Chenjie Xie; Jing Wang; Ji Ma; Shijian Liu; Li Xie; Yijie Zheng; Rui Dong; Shan Wang; Yongjun Fang; Yurui Wu; Xianwei Zhang; Xianying Lu; Yang Li; Weisong Li; Qiuhui Pan; Min Xu; Song Gu

Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical data

BMC Cancer 17(1) (2017)

Rentao Yu; Zhaoxia Tan; Xiaomei Xiang; Yunjie Dan; Guohong Deng

DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma

Cancers 15(18) (2023)

Chang-Yi Lu; Chih-Yang Hsiao; Pey-Jey Peng; Shao-Chang Huang; Meng-Rong Chuang; Hung-Ju Su; Kai-Wen Huang

Characterization of Gla proteoforms and non-Gla peptides of gamma carboxylated proteins: Application to quantification of prothrombin proteoforms in human plasma

Analytica Chimica Acta 1284 (2023)

Dilip Kumar Singh; Abdul Basit; Allan E. Rettie; Nathan Alade; Kenneth Thummel; Bhagwat Prasad